RxDoctor Payments Data

William Faltermayer, DO

Family Medicine · Hickory, NCNPI 1598767006

Payments from drug & device makers

$162in general payments, 2019–2025

Across 9 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Irhythm Technologies, Inc.$52
  • Insulet Corporation$22
  • Sanofi-aventis U.S. LLC$19
  • AbbVie$19
  • Novo Nordisk$13
  • Dexcom, Inc.$13
  • plus $24 from 2 others

What the payments were for

  • Food & beverage$162100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$162 in reported general payments places this provider in the 35th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$91,445
Medicare patients
158
Services billed
2,282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate33$39,978
JardianceEmpagliflozin37$36,914
OzempicSemaglutide23$27,183
Janumet XrSitagliptin Phos/Metformin Hcl37$24,736
RybelsusSemaglutide19$19,438
Tresiba Flextouch U-200Insulin Degludec14$17,409
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$14,845
EliquisApixaban13$13,280
Humalog Kwikpen U-200Insulin Lispro17$5,820
SymbicortBudesonide/Formoterol Fumarate16$4,687
Incruse ElliptaUmeclidinium Bromide12$4,346
LivaloPitavastatin Calcium11$4,324
Wixela InhubFluticasone Propion/Salmeterol22$3,406
Atorvastatin Calcium311$2,539
Omeprazole201$2,344

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$13$46,62142 claims
AbbVieSynthroid$19$98211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →